XThis page contains elements that are not optimised for mobile viewing. Click the link below to view the page in desktop mode.
Desktop mode
Theme

Reimbursement for medicine

Read about how much you can get in reimbursement for your medicine, which types of reimbursement you can get in Denmark, and what the rules are for the different types of reimbursement.

Go to theme
Theme

Strategy for the DKMA

The Danish Medicines Agency has formulated a strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.

Go to theme
indgangsikon nr 1

General public

Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public.

indgangsikon nr 2

Industry

Information on licensing, inspections, fees, company authorisations, clinical trials and more.

indgangsikon nr 3

Healthcare professionals

This section gathers information for doctors, nurses, pharmacies, dentists and other healthcare professionals.

News

Control of companies' uploading of leaflets to the Danish Medicines Agency's portal DKMAnet

16 October 2024

The Danish Medicines Agency's laboratory will regularly select ATC groups and check whether readable package leaflets have been uploaded to www.indlaegsseddel.dk. The selected ATC groups will not be published in advance.

2024 deadline for submitting applications concerning marketing authorisations and clinical trials

05 November 2024

Updated version of the Danish Medicines Agency's guidance on risk-adapted recording and reporting of adverse events in clinical trials is now available on the website

23 October 2024

Nils Falk Bjerregaard new Director General of the Danish Medicines Agency

03 October 2024